• Username (E-mail)
  • Password
Dow 21,141 1.6%  EStoxx50 3,390 2.1%  Nikkei 19,394 1.4%  EUR 1.0551 -0.2% 
Nasdaq 5,905 1.4%  FTSE100 7,383 1.6%  Yen 113.6540 0.7%  Oil 56.4 1.5% 
S&P500 2,398 1.4%  DAX 12,067 2.0%  GBP 1.2292 -0.7%  Gold 1,250 0.1% 

Vertex Pharmaceuticals share [Symbol: VRTX / ISIN: US92532F1003]

10/25/2016 04:07:29 PM
10/25/2016 04:07:29 PM UTC-0400

EARNINGS SUMMARY: Details of Vertex Pharmaceuticals Inc. Q3 Earnings Report


(RTTNews) - Below are the earnings highlights for Vertex Pharmaceuticals Inc. (VRTX):

-Earnings: $40 million in Q3 vs. -$32 million in the same period last year. -EPS: $0.16 in Q3 vs. -$0.13 in the same period last year. -Analysts projected $0.18 per share -Revenue: $234 million in Q3 vs. $131 million in the same period last year.

Analyst Opinions for Vertex Pharmaceuticals Inc.

More Analyst Opinions
  • All
  • Buy
  • Hold
  • Sell
12/14/12
Vertex Pharmaceuticals Goldman Sachs Group Inc.
12/05/12
Vertex Pharmaceuticals RBC Capital Markets
11/13/12
Vertex Pharmaceuticals Credit Suisse Group
11/05/12
Vertex Pharmaceuticals Goldman Sachs Group Inc.
11/02/12
Vertex Pharmaceuticals UBS AG

Add or Edit Instrument

Related Stocks

Stock Market

News Ticker

News

  • News on Stocks
  • All News
pagehit